IP Library Assignment 046835/0350
Patent Assignment
Reel/Frame 046835/0350

Change of Address

Recorded: 2018-08-24 Pages: 8
Assignor
SENJU PHARMACEUTICAL CO., LTD.
Executed: 2018-03-12
Assignee
SENJU PHARMACEUTICAL CO., LTD.
3-1-9, KAWARA-MACHI, CHUO-KU, OSAKA-SHI, OSAKA, 541-0048, JAPAN
Covered Properties (68)
Stable Aqueous Solution
Application: 14/764,537 →
Publication: US 2015/0366966
Clear Aqueous Solution
Patent: 9,968,679 →
Application: 14/763,304 →
Publication: US 2015/0366969
Clear Aqueous Solution
Application: 15/953,557 →
Publication: US 2018/0228901
Difluprednate Emulsion Composition Containing Zinc
Application: 14/766,923 →
Publication: US 2015/0374820
Difluprednate Emulsion Composition Containing Antimicrobial Metal
Application: 14/767,218 →
Publication: US 2015/0366879
Differentiation Marker and Differentiation Control of Eye Cell
Application: 15/443,913 →
Publication: US 2017/0202910
Corneal Endothelium Ecm Therapeutic Medicaments
Application: 14/907,881 →
Publication: US 2016/0158210
Therapeutic Drug for Diseases Related to Endoplasmic Reticulum Cell Death in Corneal Endothelium
Application: 15/031,183 →
Publication: US 2016/0296505
Combined Agent for Cell Therapy of Corneal Endothelial Cell
Application: 15/108,355 →
Publication: US 2016/0317528
Application of Laminin to Corneal Endothelial Cell Culture
Application: 15/100,147 →
Publication: US 2017/0002318
Anionic Drug-Containing Medical Device
Application: 15/304,409 →
Publication: US 2017/0043017
Novel Treatment of Cornea Using Laminin
Application: 15/523,231 →
Publication: US 2017/0319693
Intraocular Surgery System
Application: 15/305,906 →
Publication: US 2017/0042731
Aqueous Liquid Agent
Application: 15/534,915 →
Publication: US 2018/0028667
Treatment of Retina and Nerve Using Laminin
Application: 15/523,282 →
Publication: US 2017/0319665
Therapeutic Agent for Neurotrophic Keratopathy
Application: 15/580,979 →
Publication: US 2018/0177766
Method for Preparation of Retinal Ganglion Cells
Application: 15/502,321 →
Publication: US 2017/0191033
Agent for Prevention or Treatement of Corneal Disorders
Application: 15/566,640 →
Publication: US 2018/0105563
Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye
Application: 10/540,835 →
Publication: US 2006/0036220
Methods for Treatment of Ophthalmic Disease of an External Ophthalmic Tissue
Application: 12/712,459 →
Publication: US 2010/0150992
Methods of Treating Corneal Related Diseases by Corneal Endothelial Preparation Which Enables Cells to Grow in Vivo
Application: 12/161,433 →
Publication: US 2010/0233240
Agent for Promoting Corneal Endothelial Cell Adhesion
Application: 14/879,658 →
Publication: US 2016/0030410
Agent for Promoting Corneal Endothelial Cell Adhesion
Application: 14/879,857 →
Publication: US 2016/0101113
Eye Drop with Difluprednate for Macular Edema Treatment
Application: 15/866,744 →
Publication: US 2018/0133153
Corneal Endothelial Cell Marker
Application: 14/908,036 →
Publication: US 2016/0266114
Normalization of Culture of Corneal Endothelial Cells
Application: 14/369,050 →
Publication: US 2015/0044178
Ophthalmic Compositions for Soft Contact Lens, Method of Enhancing Wettability of Soft Contact Lens, and Method of Inhibiting Terpenoid Adsorption
Patent: 6,545,058 →
Application: 09/486,212 →
Publication: US 2002/0010193
Ophthalmic Compositions for Soft Contact Lens, Method of Enhancing Wettability of Soft Contact Lens and Method of Inhibiting Terpenoid Adsorption
Patent: 6,479,556 →
Application: 09/931,764 →
Publication: US 2002/0052419
Packaged Ophthalmic Perfusate and Cleaning Fluid Bag
Patent: 6,764,481 →
Application: 09/530,507 →
Method of Packaging Ocular Irrigating Solution
Patent: 7,047,708 →
Application: 10/735,639 →
Publication: US 2004/0123563
Prolonged-action eye drop
Patent: 6,335,335 →
Application: 09/802,860 →
Publication: US 2001/0041721
Prolonged-Action Eye Drop
Patent: 6,645,963 →
Application: 09/802,849 →
Publication: US 2001/0012859
Vitamin E Derivatives
Patent: 6,387,882 →
Application: 09/581,588 →
Preventives or Remedies for Vision Disorders
Patent: 6,268,359 →
Application: 09/601,216 →
Differentiation Marker and Differentiation Control of Eye Cell
Patent: 9,616,101 →
Application: 14/413,066 →
Publication: US 2015/0202256
Therapeutic Agent for Corneal Epithelial Disorder
Patent: 9,562,231 →
Application: 14/914,962 →
Publication: US 2016/0208250
Two-Layer Separation-Type Eye Drop Containing Squalane
Patent: 9,907,750 →
Application: 14/778,359 →
Publication: US 2016/0067181
Annular Device
Patent: 9,921,419 →
Application: 14/890,871 →
Publication: US 2016/0103336
Alkynyl Indazole Derivative and Use Thereof
Patent: 9,617,222 →
Application: 15/126,730 →
Publication: US 2017/0096400
Drug-Releasing System of Biodegradable Polymer Type
Patent: 7,850,993 →
Application: 10/468,585 →
Publication: US 2004/0076676
A Method of Suppressing Melanin Production by Metal Chelates of Lipoyl Amino Acid Derivatives
Patent: 7,700,080 →
Application: 10/472,726 →
Publication: US 2004/0092586
L-Ascorbic Acid-2-O-Maleic Acid-a-Tocopherol Diester 1-Propanol Adduct and Process for Producing the Same
Patent: 6,828,348 →
Application: 10/479,145 →
Publication: US 2004/0171676
Intraocular Surgical Apparatus
Patent: 6,723,065 →
Application: 09/741,031 →
Publication: US 2002/0095113
Decompression-Compensating Instrument for Ocular Surgery, Instrument for Ocular Surgery Provided with the Same and Method of Ocular Surgery
Patent: 7,303,566 →
Application: 10/512,867 →
Publication: US 2006/0058811
Packaged Container Containing Ocular Perfusion/Washing Solution and Process for Producing the Same
Patent: 7,347,324 →
Application: 10/522,681 →
Publication: US 2006/0118433
Alpha-Ketoamide Derivative, and Production Method and Use Thereof
Patent: 7,491,705 →
Application: 10/582,015 →
Publication: US 2007/0004643
Percutaneously Absorptive Ophthalmic Preparation Comprising Olopatadine
Patent: 8,101,654 →
Application: 11/988,377 →
Publication: US 2009/0209632
Ophthalmic Composition Containing Xanthan Gum and Amino Acid
Patent: 7,939,511 →
Application: 11/663,771 →
Publication: US 2008/0039423
Ophthalmic Composition Containing Xanthan Gum and Amino Acid
Patent: 8,450,295 →
Application: 12/767,185 →
Publication: US 2012/0269845
Aqueous Intraocular Penetration-Promoting Eye Drop
Patent: 8,299,124 →
Application: 13/332,827 →
Publication: US 2012/0095101
Aqueous Intraocular Penetration-Promoting Eye Drop
Patent: 8,518,996 →
Application: 13/616,810 →
Publication: US 2013/0005815
Eye Drop Preparation Comprising Xanthan Gum and Terpenoid
Patent: 7,998,942 →
Application: 11/988,489 →
Publication: US 2009/0054531
Ophthalmic Composition Comprising Xanthan Gum and Glucose
Patent: 7,875,271 →
Application: 12/225,255 →
Publication: US 2009/0269369
Neurite Formation Promoter
Patent: 8,637,544 →
Application: 12/596,581 →
Publication: US 2010/0144792
Pharmaceutical Containing Ppar Delta Agonist
Patent: 8,802,705 →
Application: 12/451,564 →
Publication: US 2012/0270910
PHARMACEUTICAL CONTAINING PPAR-delta AGONIST
Patent: 9,463,185 →
Application: 14/317,145 →
Publication: US 2014/0343109
Pharmaceutical Containing Hif-1 Alpha and Hif-2 Alpha Expression Inhibitor
Patent: 8,268,794 →
Application: 12/672,473 →
Publication: US 2011/0213008
Agent for Promoting Corneal Endothelial Cell Adhesion
Patent: 9,248,125 →
Application: 12/675,475 →
Publication: US 2010/0209402
Partial Peptide of Lacritin
Patent: 8,383,130 →
Application: 12/922,084 →
Publication: US 2011/0008891
Solid Dispersion of Alpha-Ketoamide Derivatives
Patent: 8,697,746 →
Application: 13/182,218 →
Publication: US 2012/0016020
Ring-Shaped Device
Patent: 9,486,362 →
Application: 13/146,614 →
Publication: US 2012/0022473
Hydrogel Contact Lens for Sustained Drug Release and Drug Release Method Using Hydrogel Contact Lens for Sustained Drug Release
Patent: 8,940,318 →
Application: 13/202,547 →
Publication: US 2011/0306661
Partial Peptide of Lacritin
Patent: 8,518,412 →
Application: 13/496,437 →
Publication: US 2012/0245102
Before-Use Mixing Container
Patent: 8,684,173 →
Application: 13/260,486 →
Publication: US 2012/0024861
Eye Drop with Difluprednate for Macular Edema Treatment
Patent: 9,949,926 →
Application: 14/661,295 →
Publication: US 2015/0190340
Aqueous Liquid Bromfenac Composition Having Preservative Efficacy
Patent: 9,107,888 →
Application: 13/978,258 →
Publication: US 2013/0281537
Aqueous Liquid Bromfenac Composition Having Preservative Efficacy
Patent: 9,561,280 →
Application: 14/793,886 →
Publication: US 2015/0306222
Fragmentation Tip, Intraocular Surgery Device Provided with Same, Method for Suppressing Occurrence of Cavitation, and Cataract Surgery Method
Patent: 9,962,289 →
Application: 14/372,158 →
Publication: US 2015/0073459
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 23, 2005
From: KAWAHARA, KOHJI; ARAMOMI, YASUHIKO; OHTONRI, AKIRA; ISOWAKI, AKIHARU
To: NICHIBAN CO., LTD.; SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 017180/0476 →
Assignment of Assignor's Interest Apr 17, 2008
From: NICHIBAN CO. LTD.
To: SENJU USA, INC.
Reel/Frame 020829/0779 →
Assignment of Assignor's Interest Mar 11, 2009
From: SENJU USA, INC.
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 022375/0850 →
Assignment of Assignor's Interest Jul 24, 2015
From: SHIKAMURA, YUKO; HIGASHIMURA, YUKA
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 036173/0946 →
Assignment of Assignor's Interest Jul 30, 2015
From: SHIKAMURA, YUKO; HIGASHIMURA, YUKA
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 036215/0417 →
Assignment of Assignor's Interest Sep 10, 2015
From: IEMOTO, SUZUKA; YAMAGUCHI, MASAZUMI; YASUEDA, SHINICHI
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 036533/0481 →
Assignment of Assignor's Interest Oct 30, 2015
From: YAMAGUCHI, MASAZUMI; NISHIHATA, SHUICHI; IEMOTO, SUZUKA; YASUEDA, SHINICHI
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 036925/0159 →
Assignment of Assignor's Interest Mar 18, 2016
From: KOIZUMI, NORIKO; OKUMURA, NAOKI; KINOSHITA, SHIGERU
To: KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION; THE DOSHISHA; SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 038025/0546 →
Assignment of Assignor's Interest May 3, 2016
From: KOIZUMI, NORIKO; OKUMURA, NAOKI; KINOSHITA, SHIGERU
To: KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION; THE DOSHISHA; SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 038447/0086 →
Assignment of Assignor's Interest Aug 12, 2016
From: KOIZUMI, NORIKO; OKUMURA, NAOKI; KINOSHITA, SHIGERU
To: KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION; THE DOSHISHA; SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 039420/0876 →
Assignment of Assignor's Interest Aug 25, 2016
From: KOIZUMI, NORIKO; OKUMURA, NAOKI; KINOSHITA, SHIGERU; KRUSE, FRIEDRICH E.
To: KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION; THE DOSHISHA; SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 039543/0108 →
Assignment of Assignor's Interest Nov 1, 2016
From: OBATA, HARUKA; SHOJI, KIYOSHI; YAMAZAKI, YOSHIKO; MATSUNAGA, TORU
To: SEED CO., LTD.; SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 040185/0297 →
Assignment of Assignor's Interest Nov 17, 2016
From: KISHIMOTO, MAKOTO
To: SENJU PHARMACEUTICAL CO., LTD.; KISHIMOTO, MAKOTO
Reel/Frame 040644/0677 →
Assignment of Assignor's Interest Feb 7, 2017
From: AZUMA, NORIYUKI; TANAKA, TAKU; YOKOI, TADASHI
To: NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT; SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 041193/0334 →
Assignment of Assignor's Interest Feb 27, 2017
From: NAKAMURA, TAKAHIRO; KOIZUMI, NORIKO; OKUMURA, NAOKI; KINOSHITA, SHIGERU
To: KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION; THE DOSHISHA; SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 041388/0170 →
Assignment of Assignor's Interest Apr 28, 2017
From: KOIZUMI, NORIKO; OKUMURA, NAOKI; KINOSHITA, SHIGERU
To: KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION; THE DOSHISHA; SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 042187/0468 →
Assignment of Assignor's Interest Apr 28, 2017
From: KOIZUMI, NORIKO; OKUMURA, NAOKI; KINOSHITA, SHIGERU
To: KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION; THE DOSHISHA; SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 042186/0392 →
Assignment of Assignor's Interest Aug 28, 2017
From: MORI, YASUHIRO; YAMAGUCHI, MASAZUMI
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 043426/0837 →
Assignment of Assignor's Interest Oct 13, 2017
From: USUI, TOMOHIKO; YABUTA, CHIHO
To: THE UNIVERSITY OF TOKYO; SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 043864/0309 →
Assignment of Assignor's Interest Jan 11, 2018
From: KOBAYASHI, SHINYA; NAKAMURA, YOSHIKUNI; TARUI, TAKESHI; WADA, TOMOYUKI
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 044594/0165 →
Change of Address Aug 9, 2018
From: SENJU PHARMACEUTICAL CO., LTD.
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 046751/0117 →
Assignment of Assignor's Interest Jul 21, 2020
From: SENJU PHARMACEUTICAL CO., LTD.
To: ACTUALEYES INC.; CORNEAGEN, INC.
Reel/Frame 053267/0528 →
Assignment of Assignor's Interest Jul 21, 2020
From: THE DOSHISHA
To: ACTUALEYES INC.
Reel/Frame 053267/0466 →
Assignment of Assignor's Interest Jan 18, 2024
From: CORNEAGEN LLC
To: AURION BIOTECH, INC.
Reel/Frame 066161/0048 →
Change of Name Jan 18, 2024
From: CORNEAGEN INC.
To: CORNEAGEN LLC
Reel/Frame 066344/0915 →